 |
8 Diseases |  |
0 Trials |
|
0 Trials |  |
4 News |  |
- |||| LX1033 / Lexicon Pharma
Trial completion: A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (clinicaltrials.gov) - Nov 6, 2013
P2, N=373, Completed, Sponsor: Lexicon Pharmaceuticals
Active, not recruiting --> Completed
- LX1033 / Lexicon Pharma
Enrollment change: An Open-Label Study of Two Formulations of LX1033 in Healthy Human Subjects (clinicaltrials.gov) - Jul 18, 2012
P1, N=28, Completed, Sponsor: Lexicon Pharmaceuticals
Active, not recruiting --> Completed N=20 --> 28
- | LX1033 / Lexicon Pharma
Trial completion: An Open-Label Study of Two Formulations of LX1033 in Healthy Human Subjects (clinicaltrials.gov) - Jul 18, 2012
P1, N=28, Completed, Sponsor: Lexicon Pharmaceuticals
N=20 --> 28 Active, not recruiting --> Completed
- ||||| LX1033 / Lexicon Pharma
New P2 trial: A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (clinicaltrials.gov) - Dec 14, 2011
P2, N=373, Completed, Sponsor: Lexicon Pharmaceuticals